Human protein kinases and obesity

Advances in Experimental Medicine and Biology

Volumn 960, Issue , 2017, Pages 111-134

  Engin, Atilla ^a,b  

^a GAZI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Adenosine monophosphate (AMP) activated protein kinase (AMPK); c Jun N terminal kinase (JNK); Dual specificity kinases; Extracellular signal regulated protein kinase (ERK); Inhibitor of kappaB kinase (IKK); Lipoapoptosis; Liver kinase B1 (LKB1); Mammalian target of rapamycin (mTOR); MAPK phosphatases; Mitogen activated protein kinases (MAPK); N terminal Per ARNT Sim (PAS) kinase (PASK); Protein kinase B (Akt); Protein kinase like endoplasmic reticulum (ER) eukaryotic initiation factor 2alpha kinase (PERK); Protein kinases; Protein phosphatases

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ADENOSINE PHOSPHATE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CASEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; DUAL SPECIFICITY PHOSPHATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1BETA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 2ALPHA; INSULIN; LIVER KINASE B1; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; PER ARNT SIM KINASE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE LIKE ENDOPLASMIC RETICULUM EUKARYOTIC INITIATION FACTOR 2ALPHA KINASE; REACTIVE OXYGEN METABOLITE; SHC SIGNALING ADAPTOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ENDOPLASMIC RETICULUM STRESS; ENERGY EXPENDITURE; ENZYME PHOSPHORYLATION; FOOD INTAKE; HUMAN; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; GENETIC TRANSCRIPTION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ADIPOGENESIS; HUMANS; OBESITY; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 85020485727     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-48382-5_5     Document Type: Chapter

References (172)

1. Abe, J., M. Kusuhara, R.J. Ulevitch, B.C. Berk, and J.D. Lee. 1996. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. The Journal of Biological Chemistry 271: 16586–16590.
2. Aguiari, P., S. Leo, B. Zavan, V. Vindigni, A. Rimessi, K. Bianchi, C. Franzin, R. Cortivo, M. Rossato, R. Vettor, G. Abatangelo, T. Pozzan, P. Pinton, and R. Rizzuto. 2008. High glucose induces adipogenic differentiation of muscle-derived stem cells. Proceedings of the National Academy of Sciences of the United States of America 105: 1226–1231. doi:10.1073/pnas.0711402105.
3. Aguirre, V., T. Uchida, L. Yenush, R. Davis, and M.F. White. 2000. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). The Journal of Biological Chemistry 275: 9047–9054.
4. Alfaradhi, M.Z., D.S. Fernandez-Twinn, M.S. Martin-Gronert, B. Musial, A. Fowden, and S.E. Ozanne. 2014. Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver by maternal obesity. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 307: R26–R34. doi:10.1152/ajpregu.00049.2014.
5. Arencibia, J.M., D. Pastor-Flores, A.F. Bauer, J.O. Schulze, and R.M. Biondi. 2013. AGC protein kinases: From structural mechanism of regulation to allosteric drug development for the treatment of human diseases. Biochimica et Biophysica Acta 1834: 1302–1321. doi:10.1016/j.bbapap.2013.03.010.
6. Bae, S.S., H. Cho, J. Mu, and M.J. Birnbaum. 2003. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. The Journal of Biological Chemistry 278: 49530–49536. doi:10.1074/jbc.M306782200.
7. Bakan, A., J.S. Lazo, P. Wipf, K.M. Brummond, and I. Bahar. 2008. Toward a molecular understanding of the interaction of dual specificity phosphatases with substrates: Insights from structure-based modeling and high throughput screening. Current Medicinal Chemistry 15: 2536–2544.
8. Bashan, N., K. Dorfman, T. Tarnovscki, I. Harman-Boehm, I.F. Liberty, M. Blüher, S. Ovadia, T. Maymon-Zilberstein, R. Potashnik, M. Stumvoll, E. Avinoach, and A. Rudich. 2007. Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology 148: 2955–2962. doi:10.1210/en.2006-1369.
9. Bengoechea-Alonso, M.T., and J. Ericsson. 2009. A phosphorylation cascade controls the degradation of active SREBP1. The Journal of Biological Chemistry 284: 5885–5895. doi:10.1074/jbc.M807906200.
10. Bijland, S., S.J. Mancini, and I.P. Salt. 2013. Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. Clinical Science (London, England) 1979(124): 491–507. doi:10.1042/CS20120536.
11. Bilanges, B., and B. Vanhaesebroeck. 2010. A new tool to dissect the function of p70 S6 kinase. The Biochemical Journal 431: e1–e3. doi:10.1042/BJ20101445.
12. Blanchard, P.-G., W.T. Festuccia, V.P. Houde, P. St-Pierre, S. Brûlé, V. Turcotte, M. Côté, K. Bellmann, A. Marette, and Y. Deshaies. 2012. Major involvement of mTOR in the PPARγ-induced stimulation of adipose tissue lipid uptake and fat accretion. Journal of Lipid Research 53: 1117–1125. doi:10.1194/jlr.M021485.
13. Blanco Martínez de Morentin, P., C.R. González, A.K. Saha, L. Martins, C. Diéguez, A. Vidal-Puig, M. Tena-Sempere, and M. López. 2011. Hypothalamic AMP-activated protein kinase as a mediator of whole body energy balance. Reviews in Endocrine & Metabolic Disorders 12: 127–140. doi:10.1007/s11154-011-9165-5.
14. Blenis, J. 1993. Signal transduction via the MAP kinases: Proceed at your own RSK. Proceedings of the National Academy of Sciences of the United States of America 90: 5889–5892.
15. Bobrovnikova-Marjon, E., D. Pytel, M.J. Riese, L.P. Vaites, N. Singh, G.A. Koretzky, E.S. Witze, and J.A. Diehl. 2012. PERK utilizes intrinsic lipid kinase activity to generate phosphatidic acid, mediate Akt activation, and promote adipocyte differentiation. Molecular and Cellular Biology 32: 2268–2278. doi:10.1128/MCB.00063-12.
16. Boden, G., S. Salehi, P. Cheung, C. Homko, W. Song, C. Loveland-Jones, and S. Jayarajan. 2013. Comparison of in vivo effects of insulin on SREBP-1c activation and INSIG-1/2 in rat liver and human and rat adipose tissue. Obesity (Silver Spring, Md.) 21: 1208–1214. doi:10.1002/oby.20134.
17. Busschots, K., L.A. Lopez-Garcia, C. Lammi, A. Stroba, S. Zeuzem, A. Piiper, P.M. Alzari, S. Neimanis, J.M. Arencibia, M. Engel, J.O. Schulze, and R.M. Biondi. 2012. Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site. Chemistry & Biology 19: 1152–1163. doi:10.1016/j.chembiol.2012.07.017.
18. Capurso, C., and A. Capurso. 2012. From excess adiposity to insulin resistance: The role of free fatty acids. Vascular Pharmacology 57: 91–97. doi:10.1016/j.vph.2012.05.003.
19. Carling, D. 2005. AMP-activated protein kinase: Balancing the scales. Biochimie 87: 87–91. doi:10.1016/j.biochi.2004.10.017.
20. Carvalho-Filho, M.A., B.M. Carvalho, A.G. Oliveira, D. Guadagnini, M. Ueno, M.M. Dias, D.M. Tsukumo, S.M. Hirabara, L.F. Reis, R. Curi, J.B.C. Carvalheira, and M.J.A. Saad. 2012. Double-stranded RNA-activated protein kinase is a key modulator of insulin sensitivity in physiological conditions and in obesity in mice. Endocrinology 153: 5261–5274. doi:10.1210/en.2012-1400.
21. Cazanave, S.C., J.L. Mott, S.F. Bronk, N.W. Werneburg, C.D. Fingas, X.W. Meng, N. Finnberg, W.S. El-Deiry, S.H. Kaufmann, and G.J. Gores. 2011. Death receptor 5 signaling promotes hepatocyte lipoapoptosis. The Journal of Biological Chemistry 286: 39336–39348. doi:10.1074/jbc.M111.280420.
22. Chen, R.H., C. Sarnecki, and J. Blenis. 1992. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Molecular and Cellular Biology 12: 915–927.
23. Chiang, S.-H., M. Bazuine, C.N. Lumeng, L.M. Geletka, J. Mowers, N.M. White, J.-T. Ma, J. Zhou, N. Qi, D. Westcott, J.B. Delproposto, T.S. Blackwell, F.E. Yull, and A.R. Saltiel. 2009. The protein kinase IKKepsilon regulates energy balance in obese mice. Cell 138: 961–975. doi:10.1016/j.cell.2009.06.046.
24. Choura, M., and A. Rebaï. 2011. Receptor tyrosine kinases: From biology to pathology. Journal of Receptor and Signal Transduction Research 31: 387–394. doi:10.3109/10799893.2011.625425.
25. Cohen, P. 2002. The origins of protein phosphorylation. Nature Cell Biology 4: E127–E130. doi:10.1038/ncb0502-e127.
26. Collins, B.J., M. Deak, V. Murray-Tait, K.G. Storey, and D.R. Alessi. 2005. In vivo role of the phosphate groove of PDK1 defined by knockin mutation. Journal of Cell Science 118: 5023–5034. doi:10.1242/jcs.02617.
27. Crews, C.M., A. Alessandrini, and R.L. Erikson. 1992. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 258: 478–480.
28. da Silva Xavier, G., J. Rutter, and G.A. Rutter. 2004. Involvement of Per-Arnt-Sim (PAS) kinase in the stimulation of preproinsulin and pancreatic duodenum homeobox 1 gene expression by glucose. Proceedings of the National Academy of Sciences of the United States of America 101: 8319–8324. doi:10.1073/pnas.0307737101.
29. Danai, L.V., A. Guilherme, K.V. Guntur, J. Straubhaar, S.M. Nicoloro, and M.P. Czech. 2013. Map4k4 suppresses Srebp-1 and adipocyte lipogenesis independent of JNK signaling. Journal of Lipid Research 54: 2697–2707. doi:10.1194/jlr.M038802.
30. Dann, S.G., A. Selvaraj, and G. Thomas. 2007. mTOR Complex1-S6K1 signaling: At the crossroads of obesity, diabetes and cancer. Trends in Molecular Medicine 13: 252–259. doi:10.1016/j.molmed.2007.04.002.
31. Davis, R.J. 1994. MAPKs: New JNK expands the group. Trends in Biochemical Sciences 19: 470–473.
32. Davis, R.J. Signal transduction by the JNK group of MAP kinases. Cell 103: 239–252.
33. De Marchi, E., F. Baldassari, A. Bononi, M.R. Wieckowski, and P. Pinton. 2013. Oxidative stress in cardiovascular diseases and obesity: Role of p66Shc and protein kinase C. Oxidative Medicine and Cellular Longevity 2013: 564961. doi:10.1155/2013/564961.
34. de Paula, R.M., T.M. Lamb, L. Bennett, and D. Bell-Pedersen. 2008. A connection between MAPK pathways and circadian clocks. Cell Cycle (Georgetown, Texas) 7: 2630–2634. doi:10.4161/cc.7.17.6516.
35. Dérijard, B., J. Raingeaud, T. Barrett, I.H. Wu, J. Han, R.J. Ulevitch, and R.J. Davis. 1995. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267: 682–685.
36. Dhanasekaran, N., and E. Premkumar Reddy. 1998. Signaling by dual specificity kinases. Oncogene 17: 1447–1455. doi:10.1038/sj.onc.1202251.
37. Dibble, C.C., and B.D. Manning. 2013. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nature Cell Biology 15: 555–564. doi:10.1038/ncb2763.
38. Ding, Y., J. Li, S. Liu, L. Zhang, H. Xiao, J. Li, H. Chen, R.B. Petersen, K. Huang, and L. Zheng. 2014. DNA hypomethylation of inflammation-associated genes in adipose tissue of female mice after multigenerational high fat diet feeding. International Journal of Obesity 38: 198–204. doi:10.1038/ijo.2013.98.
39. Ducruet, A.P., A. Vogt, P. Wipf, and J.S. Lazo. 2005. Dual specificity protein phosphatases: Therapeutic targets for cancer and Alzheimer’s disease. Annual Review of Pharmacology and Toxicology 45: 725–750. doi:10.1146/annurev.pharmtox.45.120403.100040.
40. Dunlop, E.A., and A.R. Tee. 2013. The kinase triad, AMPK, mTORC1 and ULK1, maintains energy and nutrient homoeostasis. Biochemical Society Transactions 41: 939–943. doi:10.1042/BST20130030.
41. Egan, D., J. Kim, R.J. Shaw, and K.-L. Guan. 2011. The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy 7: 643–644.
42. Emanuelli, B., P. Peraldi, C. Filloux, C. Chavey, K. Freidinger, D.J. Hilton, G.S. Hotamisligil, and E. Van Obberghen. 2001. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. The Journal of Biological Chemistry 276: 47944–47949. doi:10.1074/jbc.M104602200.
43. Emanuelli, B., D. Eberlé, R. Suzuki, and C.R. Kahn. 2008. Overexpression of the dual-specificity phosphatase MKP-4/DUSP-9 protects against stress-induced insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 105: 3545–3550. doi:10.1073/pnas.0712275105.
44. Farese, R.V., and M.P. Sajan. 2010. Metabolic functions of atypical protein kinase C: “Good” and “bad” as defined by nutritional status. American Journal of Physiology. Endocrinology and Metabolism 298: E385–E394. doi:10.1152/ajpendo.00608.2009.
45. Farese, R.V., M.P. Sajan, and M.L. Standaert. 2005. Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): Actions and defects in obesity and type II diabetes. Experimental Biology and Medicine (Maywood, N.J.) 230: 593–605.
46. Farmer, S.R. 2006. Transcriptional control of adipocyte formation. Cell Metabolism 4: 263–273. doi:10.1016/j.cmet.2006.07.001.
47. Fernandez-Twinn, D.S., H.L. Blackmore, L. Siggens, D.A. Giussani, C.M. Cross, R. Foo, and S.E. Ozanne. 2012. The programming of cardiac hypertrophy in the offspring by maternal obesity is associated with hyperinsulinemia, AKT, ERK, and mTOR activation. Endocrinology 153: 5961–5971. doi:10.1210/en.2012-1508.
48. Fernández-Veledo, S., A. Vázquez-Carballo, R. Vila-Bedmar, V. Ceperuelo-Mallafré, and J. Vendrell. 2013. Role of energy- and nutrient-sensing kinases AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in adipocyte differentiation. IUBMB Life 65: 572–583. doi:10.1002/iub.1170.
49. Flach, R.J.R., H. Qin, L. Zhang, and A.M. Bennett. 2011. Loss of mitogen-activated protein kinase phosphatase- 1 protects from hepatic steatosis by repression of cell death-inducing DNA fragmentation factor A (DFFA)- like effector C (CIDEC)/fat-specific protein 27. The Journal of Biological Chemistry 286: 22195–22202. doi:10.1074/jbc.M110.210237.
50. Frost, J.A., H. Steen, P. Shapiro, T. Lewis, N. Ahn, P.E. Shaw, and M.H. Cobb. 1997. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. The EMBO Journal 16: 6426–6438. doi:10.1093/emboj/16.21.6426.
51. Gao, D., S. Nong, X. Huang, Y. Lu, H. Zhao, Y. Lin, Y. Man, S. Wang, J. Yang, and J. Li. 2010. The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. The Journal of Biological Chemistry 285: 29965–29973. doi:10.1074/jbc.M110.128694.
52. Gardner, B.M., D. Pincus, K. Gotthardt, C.M. Gallagher, and P. Walter. 2013. Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harbor Perspectives in Biology 5: a013169. doi:10.1101/cshperspect.a013169.
53. Geng, T., W. Hu, M.H. Broadwater, J.M. Snider, J. Bielawski, S.B. Russo, J.H. Schwacke, J. Ross, and L.A. Cowart. 2013. Fatty acids differentially regulate insulin resistance through endoplasm reticulum stress-mediated induction of tribbles homologue 3: A potential link between dietary fat composition and the pathophysiological outcomes of obesity. Diabetologia 56: 2078–2087. doi:10.1007/s00125-013-2973-2.
54. Giardina, J.B., D.J. Tanner, and R.A. Khalil. 2001. Oxidized-LDL enhances coronary vasoconstriction by increasing the activity of protein kinase C isoforms alpha and epsilon. Hypertension (Dallas, Tex.: 1979) 37: 561–568.
55. Gil, A., C. María Aguilera, M. Gil-Campos, and R. Cañete. 2007. Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity. The British Journal of Nutrition 98(Suppl 1): S121–S126. doi:10.1017/S0007114507838050.
56. Goldsmith, C.S., and D. Bell-Pedersen. 2013. Diverse roles for MAPK signaling in circadian clocks. Advances in Genetics 84: 1–39. doi:10.1016/B978-0-12-407703-4.00001-3.
57. Gonzalez, F.A., A. Seth, D.L. Raden, D.S. Bowman, F.S. Fay, and R.J. Davis. 1993. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. The Journal of Cell Biology 122: 1089–1101.
58. González-Périz, A., R. Horrillo, N. Ferré, K. Gronert, B. Dong, E. Morán-Salvador, E. Titos, M. Martínez-Clemente, M. López-Parra, V. Arroyo, and J. Clària. 2009. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: A role for resolvins and protectins. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 23: 1946–1957. doi:10.1096/fj.08-125674.
59. Graves, D., C. Bartleson, A. Biorn, and M. Pete. 1999. Substrate and inhibitor recognition of protein kinases: What is known about the catalytic subunit of phosphorylase kinase? Pharmacology & Therapeutics 82: 143–155.
60. Grose, J.H., and J. Rutter. 2010. The role of PAS kinase in PASsing the glucose signal. Sensors 10: 5668–5682. doi:10.3390/s100605668.
61. Gual, P., Y. Le Marchand-Brustel, and J.-F. Tanti. 2005. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87: 99–109. doi:10.1016/j.biochi.2004.10.019.
62. Häcker, H., and M. Karin. 2006. Regulation and function of IKK and IKK-related kinases. Science’s STKE: Signal Transduction Knowledge Environment 2006: re13. doi:10.1126/stke.3572006re13.
63. Han, J., and R.J. Kaufman. 2014. Measurement of the unfolded protein response to investigate its role in adipogenesis and obesity. Methods in Enzymology 538: 135–150. doi:10.1016/B978-0-12-800280-3.00008-6.
64. Hao, H.-X., and J. Rutter. 2008. The role of PAS kinase in regulating energy metabolism. IUBMB Life 60: 204–209. doi:10.1002/iub.32.
65. He, S., and Y.-X. Tao. 2014. Defect in MAPK signaling as a cause for monogenic obesity aused by inactivating mutations in the melanocortin-4 receptor gene. International Journal of Biological Sciences 10: 1128–1137. doi:10.7150/ijbs.10359.
66. Hirosumi, J., G. Tuncman, L. Chang, C.Z. Görgün, K.T. Uysal, K. Maeda, M. Karin, and G.S. Hotamisligil. 2002. A central role for JNK in obesity and insulin resistance. Nature 420: 333–336. doi:10.1038/nature01137.
67. Hotamisligil, G.S. 2006. Inflammation and metabolic disorders. Nature 444: 860–867. doi:10.1038/nature05485.
68. Hotamisligil, G.S. 2008. Inflammation and endoplasmic reticulum stress in obesity and diabetes. International Journal of Obesity 2005(32 Suppl 7): S52–S54. doi:10.1038/ijo.2008.238.
69. Hotamisligil, G.S. 2010. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140: 900–917. doi:10.1016/j.cell.2010.02.034.
70. Humphrey, S.J., G. Yang, P. Yang, D.J. Fazakerley, J. Stöckli, J.Y. Yang, and D.E. James. 2013. Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2. Cell Metabolism 17: 1009–1020. doi:10.1016/j.cmet.2013.04.010.
71. Jaeschke, A., and R.J. Davis. 2007. Metabolic stress signaling mediated by mixed-lineage kinases. Molecular Cell 27: 498–508. doi:10.1016/j.molcel.2007.07.008.
72. Jaeschke, A., M.P. Czech, and R.J. Davis. 2004. An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue. Genes & Development 18: 1976–1980. doi:10.1101/gad.1216504.
73. Jiao, P., J. Ma, B. Feng, H. Zhang, J.A. Diehl, Y.E. Chin, W. Yan, and H. Xu. 2011. FFA-induced adipocyte inflammation and insulin resistance: Involvement of ER stress and IKKβ pathways. Obesity (Silver Spring, Md.) 19: 483–491. doi:10.1038/oby.2010.200.
74. Johnson, L.N., and R.J. Lewis. 2001. Structural basis for control by phosphorylation. Chemical Reviews 101: 2209–2242.
75. Kaneto, H., T.-A. Matsuoka, Y. Nakatani, D. Kawamori, T. Miyatsuka, M. Matsuhisa, and Y. Yamasaki. 2005. Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes. Journal of Molecular Medicine (Berlin, Germany) 83: 429–439. doi:10.1007/s00109-005-0640-x.
76. Kaplon, R.E., E. Chung, L. Reese, K. Cox-York, D.R. Seals, and C.L. Gentile. 2013. Activation of the unfolded protein response in vascular endothelial cells of nondiabetic obese adults. The Journal of Clinical Endocrinology and Metabolism 98: E1505–E1509. doi:10.1210/jc.2013-1841.
77. Kauppinen, A., T. Suuronen, J. Ojala, K. Kaarniranta, and A. Salminen. 2013. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Cellular Signalling 25: 1939–1948. doi:10.1016/j.cellsig.2013.06.007.
78. Kim, Y.-B., K. Kotani, T.P. Ciaraldi, R.R. Henry, and B.B. Kahn. 2003. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: Reversal with weight reduction. Diabetes 52: 1935–1942.
79. Kim, M.-S., Y.K. Pak, P.-G. Jang, C. Namkoong, Y.-S. Choi, J.-C. Won, K.-S. Kim, S.-W. Kim, H.-S. Kim, J.-Y. Park, Y.-B. Kim, and K.-U. Lee. 2006. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nature Neuroscience 9: 901–906. doi:10.1038/nn1731.
80. Körner, A., W. Kiess, M. Stumvoll, and P. Kovacs. 2008. Polygenic contribution to obesity: Genome-wide strategies reveal new targets. Frontiers of Hormone Research 36: 12–36. doi:10.1159/0000115335.
81. Lagace, T.A., and N.D. Ridgway. 2013. The role of phospholipids in the biological activity and structure of the endoplasmic reticulum. Biochimica et Biophysica Acta 1833: 2499–2510. doi:10.1016/j.bbamcr.2013.05.018.
82. Le Marchand-Brustel, Y., P. Gual, T. Grémeaux, T. Gonzalez, R. Barrès, and J.-F. Tanti. 2003. Fatty acid-induced insulin resistance: Role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling. Biochemical Society Transactions 31: 1152–1156 .doi:10.1042/bst0311152.
83. Lee, Y., and E.-K. Kim. 2013. AMP-activated protein kinase as a key molecular link between metabolism and clockwork. Experimental & Molecular Medicine 45: e33. doi:10.1038/emm.2013.65.
84. Lee, S., and F.T.F. Tsai. 2005. Molecular chaperones in protein quality control. Journal of Biochemistry and Molecular Biology 38: 259–265.
85. Lee, Y.H., J. Giraud, R.J. Davis, and M.F. White. 2003. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. The Journal of Biological Chemistry 278: 2896–2902. doi:10.1074/jbc.M208359200.
86. Lee, W.J., E.H. Koh, J.C. Won, M.-S. Kim, J.-Y. Park, and K.-U. Lee. 2005. Obesity: The role of hypothalamic AMP-activated protein kinase in body weight regulation. The International Journal of Biochemistry & Cell Biology 37: 2254–2259. doi:10.1016/j.biocel.2005.06.019.
87. Li, H., and X. Yu. 2013. Emerging role of JNK in insulin resistance. Current Diabetes Reviews 9: 422–428.
88. Li, H., J. Lee, C. He, M.-H. Zou, and Z. Xie. 2014a. Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids. American Journal of Physiology. Endocrinology and Metabolism 306: E197–E209. doi:10.1152/ajpendo.00202.2013.
89. Li, H., Q. Min, C. Ouyang, J. Lee, C. He, M.-H. Zou, and Z. Xie. 2014b. AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response. Biochimica et Biophysica Acta 1842: 1844–1854. doi:10.1016/j.bbadis.2014.07.002.
90. Lindberg, R.A., A.M. Quinn, and T. Hunter. 1992. Dual-specificity protein kinases: Will any hydroxyl do? Trends in Biochemical Sciences 17: 114–119.
91. Malhi, H., S.F. Bronk, N.W. Werneburg, and G.J. Gores. 2006. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. The Journal of Biological Chemistry 281: 12093–12101. doi:10.1074/jbc.M510660200.
92. Manning, B.D., and L.C. Cantley. 2007. AKT/PKB signaling: Navigating downstream. Cell 129: 1261–1274. doi:10.1016/j.cell.2007.06.009.
93. Manning, G., G.D. Plowman, T. Hunter, and S. Sudarsanam. 2002a. Evolution of protein kinase signaling from yeast to man. Trends in Biochemical Sciences 27: 514–520.
94. Manning, G., D.B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam. 2002b. The protein kinase complement of the human genome. Science 298: 1912–1934. doi:10.1126/science.1075762.
95. Martin, T.L., T. Alquier, K. Asakura, N. Furukawa, F. Preitner, and B.B. Kahn. 2006. Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. The Journal of Biological Chemistry 281: 18933–18941. doi:10.1074/jbc.M512831200.
96. Matsuzaki, H., H. Daitoku, M. Hatta, K. Tanaka, and A. Fukamizu. 2003. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proceedings of the National Academy of Sciences of the United States of America 100: 11285–11290. doi:10.1073/pnas.1934283100.
97. Mizukami, Y., K. Yoshioka, S. Morimoto, and K.I. Yoshida. 1997. A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion. The Journal of Biological Chemistry 272: 16657–16662.
98. Mora, A., D. Komander, D.M.F. van Aalten, and D.R. Alessi. 2004. PDK1, the master regulator of AGC kinase signal transduction. Seminars in Cell & Developmental Biology 15: 161–170.
99. Nakamura, T., M. Furuhashi, P. Li, H. Cao, G. Tuncman, N. Sonenberg, C.Z. Gorgun, and G.S. Hotamisligil. 2010. Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 140: 338–348. doi:10.1016/j.cell.2010.01.001.
100. Nguyen, M.T.A., H. Satoh, S. Favelyukis, J.L. Babendure, T. Imamura, J.I. Sbodio, J. Zalevsky, B.I. Dahiyat, N.-W. Chi, and J.M. Olefsky. 2005. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. The Journal of Biological Chemistry 280: 35361–35371. doi:10.1074/jbc.M504611200.
101. Odegaard, J.I., R.R. Ricardo-Gonzalez, M.H. Goforth, C.R. Morel, V. Subramanian, L. Mukundan, A. Red Eagle, D. Vats, F. Brombacher, A.W. Ferrante, and A. Chawla. 2007. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447: 1116–1120. doi:10.1038/nature05894.
102. Ogborn, D.I., B.R. McKay, J.D. Crane, G. Parise, and M.A. Tarnopolsky. 2014. The unfolded protein response is triggered following a single, unaccustomed resistance-exercise bout. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 307: R664–R669. doi:10.1152/ajpregu.00511.2013.
103. Owen, D.J., M.E. Noble, E.F. Garman, A.C. Papageorgiou, and L.N. Johnson. 1995. Two structures of the catalytic domain of phosphorylase kinase: An active protein kinase complexed with substrate analogue and product. Structure (London, England: 1993) 1993(3): 467–482.
104. Ozcan, L., C.C.L. Wong, G. Li, T. Xu, U. Pajvani, S.K.R. Park, A. Wronska, B.-X. Chen, A.R. Marks, A. Fukamizu, J. Backs, H.A. Singer, J.R. Yates, D. Accili, and I. Tabas. 2012. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metabolism 15: 739–751. doi:10.1016/j.cmet.2012.03.002.
105. Ozcan, L., J. Cristina de Souza, A.A. Harari, J. Backs, E.N. Olson, and I. Tabas. 2013. Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling. Cell Metabolism 18: 803–815. doi:10.1016/j.cmet.2013.10.011.
106. Paquot, N., J. De Flines, and M. Rorive. 2012. Obesity: A model of complex interactions between genetics and environment. Revue Médicale de Liège 67: 332–336.
107. Park, J., W.-J. Song, and K.C. Chung. 2009. Function and regulation of Dyrk1A: Towards understanding Down syndrome. Cellular and Molecular Life Sciences: CMLS 66: 3235–3240. doi:10.1007/s00018-009-0123-2.
108. Patterson, K.I., T. Brummer, P.M. O’Brien, and R.J. Daly. 2009. Dual-specificity phosphatases: Critical regulators with diverse cellular targets. The Biochemical Journal 418: 475–489.
109. Pawson, T., and J.D. Scott. 2005. Protein phosphorylation in signaling—50 years and counting. Trends in Biochemical Sciences 30: 286–290. doi:10.1016/j.tibs.2005.04.013.
110. Pearce, N.J., J.R.S. Arch, J.C. Clapham, M.P. Coghlan, S.L. Corcoran, C.A. Lister, A. Llano, G.B. Moore, G.J. Murphy, S.A. Smith, C.M. Taylor, J.W. Yates, A.D. Morrison, A.J. Harper, L. Roxbee-Cox, A. Abuin, E. Wargent, and J.C. Holder. 2004. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter. Metabolism 53: 1322–1330.
111. Pihl, E., K. Zilmer, T. Kullisaar, C. Kairane, A. Mägi, and M. Zilmer. 2006. Atherogenic inflammatory and oxidative stress markers in relation to overweight values in male former athletes. International Journal of Obesity 2005(30): 141–146. doi:10.1038/sj.ijo.0803068.
112. Poitout, V., and R.P. Robertson. 2008. Glucolipotoxicity: Fuel excess and beta-cell dysfunction. Endocrine Reviews 29: 351–366. doi:10.1210/er.2007-0023.
113. Pons, S., V. Martin, L. Portal, R. Zini, D. Morin, A. Berdeaux, and B. Ghaleh. 2013. Regular treadmill exercise restores cardioprotective signaling pathways in obese mice independently from improvement in associated co-morbidities. Journal of Molecular and Cellular Cardiology 54: 82–89. doi:10.1016/j.yjmcc.2012.11.010.
114. Rametta, R., E. Mozzi, P. Dongiovanni, B.M. Motta, M. Milano, G. Roviaro, S. Fargion, and L. Valenti. 2013. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects. International Journal of Obesity 2005(37): 986–992. doi:10.1038/ijo.2012.181.
115. Ranieri, S.C., S. Fusco, E. Panieri, V. Labate, M. Mele, V. Tesori, A.M. Ferrara, G. Maulucci, M. De Spirito, G.E. Martorana, T. Galeotti, and G. Pani. 2010. Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 107: 13420–13425. doi:10.1073/pnas.1008647107.
116. Ranieri, S.C., S. Fusco, and G. Pani. 2013. p66(ShcA): Linking mammalian longevity with obesity-induced insulin resistance. Vitamins and Hormones 91: 219–241. doi:10.1016/B978-0-12-407766-9.00009-2.
117. Ricoult, S.J.H., and B.D. Manning. 2013. The multifaceted role of mTORC1 in the control of lipid metabolism. EMBO Reports 14: 242–251. doi:10.1038/embor.2013.5.
118. Rodrigues, A.R., H. Almeida, and A.M. Gouveia. 2013. Alpha-MSH signalling via melanocortin 5 receptor promotes lipolysis and impairs re-esterification in adipocytes. Biochimica et Biophysica Acta 1831: 1267–1275.
119. Ron, D., and P. Walter. 2007. Signal integration in the endoplasmic reticulum unfolded protein response. Nature Reviews. Molecular Cell Biology 8: 519–529. doi:10.1038/nrm2199.
120. Roth, R.J., A.M. Le, L. Zhang, M. Kahn, V.T. Samuel, G.I. Shulman, and A.M. Bennett. 2009. MAPK phosphatase- 1 facilitates the loss of oxidative myofibers associated with obesity in mice. The Journal of Clinical Investigation 119: 3817–3829. doi:10.1172/JCI39054.
121. Roux, P.P., and J. Blenis. 2004. ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiology and Molecular Biology Reviews: MMBR 68: 320–344. doi:10.1128/MMBR.68.2.320-344.2004.
122. Rukh, G., E. Sonestedt, O. Melander, B. Hedblad, E. Wirfält, U. Ericson, and M. Orho-Melander. 2013. Genetic susceptibility to obesity and diet intakes: Association and interaction analyses in the Malmö Diet and Cancer Study. Genes & Nutrition 8: 535–547. doi:10.1007/s12263-013-0352-8.
123. Sabapathy, K., K. Hochedlinger, S.Y. Nam, A. Bauer, M. Karin, and E.F. Wagner. 2004. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Molecular Cell 15: 713–725. doi:10.1016/j.molcel.2004.08.028.
124. Sabio, G., M. Das, A. Mora, Z. Zhang, J.Y. Jun, H.J. Ko, T. Barrett, J.K. Kim, and R.J. Davis. 2008. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322: 1539–1543. doi:10.1126/science.1160794.
125. Sajan, M.P., M.E. Acevedo-Duncan, M.L. Standaert, R.A. Ivey, M. Lee, and R.V. Farese. 2014. Akt-dependent phosphorylation of hepatic FoxO1 is compartmentalized on a WD40/ProF scaffold and is selectively inhibited by aPKC in early phases of diet-induced obesity. Diabetes 63: 2690–2701. doi:10.2337/db13-1863.
126. Scazzocchio, B., R. Varì, M. D’Archivio, C. Santangelo, C. Filesi, C. Giovannini, and R. Masella. 2009. Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases. Journal of Lipid Research 50: 832–845. doi:10.1194/jlr.M800402-JLR200.
127. Schaeffer, H.J., and M.J. Weber. 1999. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Molecular and Cellular Biology 19: 2435–2444.
128. Schattenberg, J.M., R. Singh, Y. Wang, J.H. Lefkowitch, R.M. Rigoli, P.E. Scherer, and M.J. Czaja. 2006. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology (Baltimore, Md.) 43: 163–172. doi:10.1002/hep.20999.
129. Schröder, M., and R.J. Kaufman. 2005. ER stress and the unfolded protein response. Mutation Research 569: 29–63. doi:10.1016/j.mrfmmm.2004.06.056.
130. Senapedis, W.T., C.J. Kennedy, P.M. Boyle, and P.A. Silver. 2011. Whole genome siRNA cell-based screen links mitochondria to Akt signaling network through uncoupling of electron transport chain. Molecular Biology of the Cell 22: 1791–1805. doi:10.1091/mbc.E10-10-0854.
131. Shaw, R.J. 2009. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiologica (Oxford, England) 196: 65–80. doi:10.1111/j.1748-1716.2009.01972.x.
132. Shi, H., M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. The Journal of Clinical Investigation 116: 3015–3025. doi:10.1172/JCI28898.
133. Shoelson, S.E., J. Lee, and A.B. Goldfine. 2006. Inflammation and insulin resistance. The Journal of Clinical Investigation 116: 1793–1801. doi:10.1172/JCI29069.
134. Shrestha, Y.B., C.H. Vaughan, B.J. Smith, C.K. Song, D.J. Baro, and T.J. Bartness. 2010. Central melanocortin stimulation increases phosphorylated perilipin A and hormone-sensitive lipase in adipose tissues. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 299: R140–R149. doi:10.1152/ajpregu.00535.2009.
135. Song, W.-J., E.-A.C. Song, M.-S. Jung, S.-H. Choi, H.-H. Baik, B.K. Jin, J.H. Kim, and S.-H. Chung. 2015. Phosphorylation and inactivation of glycogen synthase kinase 3β (GSK3β) by dual-specificiy tyrosine phosphorylation-regulated kinase 1A (Dyrk1A). The Journal of Biological Chemistry 290: 2321–2333. doi:10.1074/jbc.M114.594952.
136. Stretton, C., A. Evans, and H.S. Hundal. 2010. Cellular depletion of atypical PKC{lambda} is associated with enhanced insulin sensitivity and glucose uptake in L6 rat skeletal muscle cells. American Journal of Physiology. Endocrinology and Metabolism 299: E402–E412. doi:10.1152/ajpendo.00171.2010.
137. Stuart, C.A., M.E.A. Howell, B.M. Cartwright, M.P. McCurry, M.L. Lee, M.W. Ramsey, and M.H. Stone. 2014. Insulin resistance and muscle insulin receptor substrate-1 serine hyperphosphorylation. Physiological Reports 2. doi:10.14814/phy2.12236
138. Subramani, S., K. Raja, and J. Natarajan. 2014. ProNormz—An integrated approach for human proteins and protein kinases normalization. Journal of Biomedical Informatics 47: 131–138. doi:10.1016/j.jbi.2013.10.003.
139. Sun, C., L. Tian, J. Nie, H. Zhang, X. Han, and Y. Shi. 2012. Inactivation of MARK4, an AMP-activated protein kinase (AMPK)-related kinase, leads to insulin hypersensitivity and resistance to diet-induced obesity. The Journal of Biological Chemistry 287: 38305–38315. doi:10.1074/jbc.M112.388934.
140. Talior, I., M. Yarkoni, N. Bashan, and H. Eldar-Finkelman. 2003. Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice. American Journal of Physiology. Endocrinology and Metabolism 285: E295–E302. doi:10.1152/ajpendo.00044.2003.
141. Tao, Y.-X. 2009. Mutations in melanocortin-4 receptor and human obesity. Progress in Molecular Biology and Translational Science 88: 173–204. doi:10.1016/S1877-1173(09)88006-X.
142. Tao, Y.-X. 2010. The melanocortin-4 receptor: Physiology, pharmacology, and pathophysiology. Endocrine Reviews 31: 506–543. doi:10.1210/er.2009-0037.
143. Taylor, S.S., C. Kim, D. Vigil, N.M. Haste, J. Yang, J. Wu, and G.S. Anand. 2005. Dynamics of signaling by PKA. Biochimica et Biophysica Acta 1754: 25–37. doi:10.1016/j.bbapap.2005.08.024.
144. Teske, B.F., S.A. Wek, P. Bunpo, J.K. Cundiff, J.N. McClintick, T.G. Anthony, and R.C. Wek. 2011. The eIF2 kinase PERK and the integrated stress response facilitate activation of ATF6 during endoplasmic reticulum stress. Molecular Biology of the Cell 22: 4390–4405. doi:10.1091/mbc.E11-06-0510.
145. Theodosiou, A., and A. Ashworth. 2002. MAP kinase phosphatases. Genome Biol. 26: 3(7):REVIEWS3009.
146. Tournier, C., C. Dong, T.K. Turner, S.N. Jones, R.A. Flavell, and R.J. Davis. 2001. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes & Development 15: 1419–1426. doi:10.1101/gad.888501.
147. Tsukumo, D.M.L., M.A. Carvalho-Filho, J.B.C. Carvalheira, P.O. Prada, S.M. Hirabara, A.A. Schenka, E.P. Araújo, J. Vassallo, R. Curi, L.A. Velloso, and M.J.A. Saad. 2007. Loss-of-function mutation in Tolllike receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56: 1986–1998. doi:10.2337/db06-1595.
148. Tuncman, G., J. Hirosumi, G. Solinas, L. Chang, M. Karin, and G.S. Hotamisligil. 2006. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 103: 10741–10746. doi:10.1073/pnas.0603509103.
149. Um, S.H., D. D’Alessio, and G. Thomas. 2006. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metabolism 3: 393–402. doi:10.1016/j.cmet.2006.05.003.
150. Uysal, K.T., S.M. Wiesbrock, M.W. Marino, and G.S. Hotamisligil. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389: 610–614. doi:10.1038/39335.
151. Valenti, L., R. Rametta, P. Dongiovanni, M. Maggioni, A.L. Fracanzani, M. Zappa, E. Lattuada, G. Roviaro, and S. Fargion. 2008. Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis. Diabetes 57: 1355–1362. doi:10.2337/db07-0714.
152. Vanhaesebroeck, B., and D.R. Alessi. 2000. The PI3K-PDK1 connection: More than just a road to PKB. The Biochemical Journal 346(Pt 3): 561–576.
153. Vila-Bedmar, R., M. Lorenzo, and S. Fernández-Veledo. 2010. Adenosine 5’-monophosphate-activated protein kinase-mammalian target of rapamycin cross talk regulates brown adipocyte differentiation. Endocrinology 151: 980–992. doi:10.1210/en.2009-0810.
154. Volmer, R., K. van der Ploeg, and D. Ron. 2013. Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains. Proceedings of the National Academy of Sciences of the United States of America 110: 4628–4633. doi:10.1073/pnas.1217611110.
155. Weston, C.R., and R.J. Davis. 2007. The JNK signal transduction pathway. Current Opinion in Cell Biology 19: 142–149. doi:10.1016/j.ceb.2007.02.001.
156. White, M.F. 2003. Insulin signaling in health and disease. Science 302: 1710–1711. doi:10.1126/science.1092952.
157. Winnay, J.N., and C.R. Kahn. 2011. PI 3-kinase regulatory subunits as regulators of the unfolded protein response. Methods in Enzymology 490: 147–158. doi:10.1016/B978-0-12-385114-7.00009-X.
158. Wu, J.J., R.J. Roth, E.J. Anderson, E.-G. Hong, M.-K. Lee, C.S. Choi, P.D. Neufer, G.I. Shulman, J.K. Kim, and A.M. Bennett. 2006. Mice lacking MAP kinase phosphatase- 1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metabolism 4: 61–73. doi:10.1016/j.cmet.2006.05.010.
159. Xu, H., M. Dembski, Q. Yang, D. Yang, A. Moriarty, O. Tayber, H. Chen, R. Kapeller, and L.A. Tartaglia. 2003. Dual specificity mitogen-activated protein (MAP) kinase phosphatase-4 plays a potential role in insulin resistance. The Journal of Biological Chemistry 278: 30187–30192. doi:10.1074/jbc.M302010200.
160. Xue, B., Z. Yang, X. Wang, and H. Shi. 2012. Omega-3 polyunsaturated fatty acids antagonize macrophage inflammation via activation of AMPK/SIRT1 pathway. PLoS One 7: e45990. doi:10.1371/journal.pone.0045990.
161. Yang, C.-Y., C.-H. Chang, Y.-L. Yu, T.-C.E. Lin, S.-A. Lee, C.-C. Yen, J.-M. Yang, J.-M. Lai, Y.-R. Hong, T.-L. Tseng, K.-M. Chao, and C.-Y.F. Huang. 2008. PhosphoPOINT: A comprehensive human kinase interactome and phospho-protein database. Bioinformatics (Oxford, England) 24: i14–i20. doi:10.1093/bioinformatics/btn297.
162. Yuan, M., N. Konstantopoulos, J. Lee, L. Hansen, Z.W. Li, M. Karin, and S.E. Shoelson. 2001. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293: 1673–1677. doi:10.1126/science.1061620.
163. Yuan, H., X. Zhang, X. Huang, Y. Lu, W. Tang, Y. Man, S. Wang, J. Xi, and J. Li. 2010. NADPH oxidase 2-derived reactive oxygen species mediate FFAs- induced dysfunction and apoptosis of β-cells via JNK, p38 MAPK and p53 pathways. PLoS One 5: e15726. doi:10.1371/journal.pone.0015726.
164. Zhang, Y., M. Xu, S. Zhang, L. Yan, C. Yang, W. Lu, Y. Li, and H. Cheng. 2007. The role of G protein-coupled receptor 40 in lipoapoptosis in mouse beta-cell line NIT-1. Journal of Molecular Endocrinology 38: 651–661. doi:10.1677/JME-06-0048.
165. Zhang, X., A. Xu, S.K. Chung, J.H.B. Cresser, G. Sweeney, R.L.C. Wong, A. Lin, and K.S.L. Lam. 2011. Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle in mice. Diabetes 60: 486–495. doi:10.2337/db10-0650.
166. Zhang, W., Q. Wang, P. Song, and M.-H. Zou. 2013. Liver kinase b1 is required for white adipose tissue growth and differentiation. Diabetes 62: 2347–2358. doi:10.2337/db12-1229.
167. Zhao, X., I.R. León, S. Bak, M. Mogensen, K. Wrzesinski, K. Højlund, and O.N. Jensen. 2011. Phosphoproteome analysis of functional mitochondria isolated from resting human muscle reveals extensive phosphorylation of inner membrane protein complexes and enzymes. Molecular & Cellular Proteomics: MCP 10: M110.000299. doi:10.1074/mcp.M110.000299.
168. Zhao, X., D. Feng, Q. Wang, A. Abdulla, X.-J. Xie, J. Zhou, Y. Sun, E.S. Yang, L.-P. Liu, B. Vaitheesvaran, L. Bridges, I.J. Kurland, R. Strich, J.-Q. Ni, C. Wang, J. Ericsson, J.E. Pessin, J.-Y. Ji, and F. Yang. 2012. Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. The Journal of Clinical Investigation 122: 2417–2427. doi:10.1172/JCI61462.
169. Zheng, C.F., and K.L. Guan. 1993. Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2. The Journal of Biological Chemistry 268: 11435–11439.
170. Zhu, J.-G., L. Xia, C.-B. Ji, C.-M. Zhang, G.-Z. Zhu, C.-M. Shi, L. Chen, D.-N. Qin, and X.-R. Guo. 2012. Differential DNA methylation status between human preadipocytes and mature adipocytes. Cell Biochemistry and Biophysics 63: 1–15. doi:10.1007/s12013-012-9336-3.
171. Zolotnik, I.A., T.Y. Figueroa, and B.B. Yaspelkis. 2012. Insulin receptor and IRS-1 co-immunoprecipitation with SOCS-3, and IKKα/β phosphorylation are increased in obese Zucer rat skeletal muscle. Life Sciences 91: 816–822. doi:10.1016/j.lfs.2012.08.038.
172. Zoncu, R., A. Efeyan, and D.M. Sabatini. 2011. mTOR: From growth signal integration to cancer, diabetes and ageing. Nature Reviews. Molecular Cell Biology 12: 21–35. doi:10.1038/nrm3025.